- Synthetic Flavours & Fragrances
- Catalyst and Auxiliary
- Agrochemicals
- Organic Chemicals
- Materials
- Basic Inorganic Chemicals
- Pharmaceutical
- Plant Extract
- Dyestuff and Pigment
- Food Additives
Zibo Kunran Enterprises Co. LTD
Country: 
China (Mainland)
China (Mainland)
Business Type: Trading Company
Ms.Mona Zhang
Tel: 0086 533 5200669
Ms.Mona Zhang
Tel: 865335200669
Ms.Minerva
Tel: 86 533 5200669
Fax: 0086 533 5207669
City: Zibo
Street: No. 96 Jinjing Avenue, Zibo, Shandong, China
MaxCard:
Doxofylline 98% CAS NO.69975-86-6
- Min.Order: 100 Gram
- Payment Terms: L/C,T/T,MoneyGram
- Product Details
Keywords
- 7-(1,3-dioxolan-2-ylmethyl)theophylline
- 3,7-dihydro-7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-1h-purine-6-dione
- CAS 69975-86-6
Quick Details
- ProName: Doxofylline 98%
- CasNo: 69975-86-6
- Molecular Formula: C11H14N4O4
- Appearance: white crystal powder
- Application: H1 antihistamine;Doxofylline is a xant...
- DeliveryTime: c.a 10 days depending on QTY
- PackAge: 25KG carton and others according to y...
- Port: Qingdao/Shanghai/Tianjin/Ningbo
- ProductionCapacity: 5 Metric Ton/Month
- Purity: min 98%
- Storage: keep it at cool, dry, ventilated place
- Transportation: by sea, air, express
- LimitNum: 100 Gram
Superiority
1. Critical raw material self-supply
2. Mature production process
3. Severe quality control system
4. Intimate after-sales service
5. Reasonable pricing
6. Factory direct supply
Details
| Product Name: | Doxofylline |
| Synonyms: | DOXOFYLLINE;DOXOPHYLLINE;7-(1,3-dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione;2-(7’-teofillinmetil)-1,3-diossolano;2-(7’-theophyllinemethyl)-1,3-dioxolane;3,7-dihydro-7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-1h-purine-6-dione;7-(1,3-dioxolan-2-ylmethyl)-theophyllin;7-(1,3-dioxolan-2-ylmethyl)theophylline |
| CAS: | 69975-86-6 |
| MF: | C11H14N4O4 |
| MW: | 266.25 |
| EINECS: | 274-239-6 |
| M.P | 144-146°C |
| Water Solubility | Soluble |
Doxofylline is an xanthine molecule that appears to be both bronchodilator and anti-inflammatory with an improved therapeutic window over conventional xanthines such as Theophylline and the evidence supporting the effects of Doxofylline in the treatment of lung diseases.